Clearside Biomedical, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 900 NORTH POINT PARKWAY, ALPHARETTA, GA, 30005
Mailing Address 900 NORTH POINT PARKWAY, ALPHARETTA, GA, 30005
Phone 678-270-3631
Fiscal Year End 1231
EIN 452437375
Financial Overview
FY2024
$34.02M
Total Assets
$48.26M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | December 29, 2025 | View on SEC |
| 8-K Current report of material events | December 8, 2025 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 7, 2025 | View on SEC |
| 8-K Current report of material events | September 11, 2025 | View on SEC |
| 8-K Current report of material events | September 11, 2025 | View on SEC |
| 8-K Current report of material events | September 8, 2025 | View on SEC |
| 8-K Current report of material events | September 3, 2025 | View on SEC |
| 8-K Current report of material events | August 14, 2025 | View on SEC |
Material Events
8-K Bankruptcy December 29, 2025
High Impact
- Clearside Biomedical, Inc. has filed for Chapter 11 bankruptcy due to serious financial trouble.
- The company is reorganizing under court supervision and plans to sell off all or most of its assets.
8-K Bankruptcy December 8, 2025
High Impact
- Clearside Biomedical, Inc. has filed for Chapter 11 bankruptcy protection (Case No. 25-12109).
- The company's stock was delisted from the Nasdaq stock exchange due to the bankruptcy filing.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.